{
    "1": {
        "question": "What are the main components of the SeC@PA microneedle (MN) bandage developed in this study?",
        "options": {
            "A": "Dopamine-coated hybrid nanoparticles containing selenium and chlorin e6",
            "B": "Copper nanoparticles and chitosan",
            "C": "Nitric oxide and silver nanoparticles",
            "D": "Gold nanoparticles and carbon nanotubes",
            "E": "Boron nanoparticles and gelatin",
            "F": "I don't know"
        }
    },
    "2": {
        "question": "Which method was used to coat the surface of Se nanoparticles?",
        "options": {
            "A": "Electroplating",
            "B": "Dopamine coating",
            "C": "Chemical vapor deposition",
            "D": "Physical vapor deposition",
            "E": "Laser ablation",
            "F": "I don't know"
        }
    },
    "3": {
        "question": "How does the SeC@PA MN bandage enhance the anti-biofilm effect of PDT?",
        "options": {
            "A": "By increasing the pH of the wound environment",
            "B": "By depleting endogenous glutathione (GSH) in biofilms",
            "C": "By reducing oxygen availability in biofilms",
            "D": "By cooling down the wound site",
            "E": "By increasing the mechanical strength of the biofilms",
            "F": "I don't know"
        }
    },
    "4": {
        "question": "What role does selenium play in the SeC@PA nanoparticles?",
        "options": {
            "A": "Acts as a reducing agent",
            "B": "Provides cross-linking with proteins",
            "C": "Facilitates the generation of reactive oxygen species (ROS)",
            "D": "Increases the temperature of the wound environment",
            "E": "Forms a gel-like matrix",
            "F": "I don't know"
        }
    },
    "5": {
        "question": "Which type of reactive species is primarily generated by the SeC@PA nanoparticles to eradicate biofilms?",
        "options": {
            "A": "Hydrogen peroxide",
            "B": "Reactive nitrogen species (RNS)",
            "C": "Singlet oxygen",
            "D": "Hydroxyl radical",
            "E": "Ozone",
            "F": "I don't know"
        }
    },
    "6": {
        "question": "What is the key advantage of the SeC@PA microneedle over traditional local delivery methods?",
        "options": {
            "A": "It is less expensive to manufacture",
            "B": "It can penetrate deeper into biofilm and inflamed tissues",
            "C": "It requires a longer application time",
            "D": "It can be used with any type of photosensitizer",
            "E": "It does not require light activation",
            "F": "I don't know"
        }
    },
    "7": {
        "question": "Which pH level accelerates the release of Ce6 from SeC@PA, according to the study?",
        "options": {
            "A": "Neutral pH of 7.0",
            "B": "Alkaline pH of 9.0",
            "C": "Weakly acidic pH of 5.5",
            "D": "Strongly acidic pH of 3.0",
            "E": "Strongly basic pH of 11.0",
            "F": "I don't know"
        }
    },
    "8": {
        "question": "What is the primary role of dopamine in the SeC@PA formulation?",
        "options": {
            "A": "To act as a photosensitizer",
            "B": "To transport nutrients to cells",
            "C": "To coat the nanoparticles and enhance adhesion",
            "D": "To produce nitric oxide",
            "E": "To enhance thermal stability",
            "F": "I don't know"
        }
    },
    "9": {
        "question": "What is the purpose of L-arginine (LA) in the SeC@PA system?",
        "options": {
            "A": "To increase rigidity of the microneedle",
            "B": "To chelate metal ions",
            "C": "To promote NO production for GSH depletion",
            "D": "To stabilize the nanoparticle surface",
            "E": "To act as a surfactant",
            "F": "I don't know"
        }
    },
    "10": {
        "question": "What effect do SeC@PA nanoparticles have on macrophage polarization?",
        "options": {
            "A": "Promote M1-phenotype polarization",
            "B": "Inhibit macrophage activity",
            "C": "Promote M2-phenotype polarization",
            "D": "Prevent macrophage differentiation",
            "E": "Reduce macrophage count",
            "F": "I don't know"
        }
    },
    "11": {
        "question": "How do SeC@PA nanoparticles affect reactive species in low GSH environments?",
        "options": {
            "A": "Increase RS levels",
            "B": "Neutralize RS as scavengers",
            "C": "Convert RS into harmless compounds",
            "D": "Prevent RS from forming",
            "E": "Cause polymerization of RS",
            "F": "I don't know"
        }
    },
    "12": {
        "question": "According to Fig. 3, how are the anti-biofilm effects of SeC@PA(+) nanoparticles assessed?",
        "options": {
            "A": "By visual inspection",
            "B": "Using live/dead staining and fluorescence microscopy",
            "C": "Assessing nano-electrical properties",
            "D": "Measuring mechanical strength",
            "E": "Evaluating magnetic response",
            "F": "I don't know"
        }
    },
    "13": {
        "question": "What type of cells are used to study the antioxidant properties of SeC@PA?",
        "options": {
            "A": "Red blood cells",
            "B": "Human dermal fibroblasts",
            "C": "Human umbilical vein endothelial cells (HUVECs)",
            "D": "Bone marrow cells",
            "E": "Rat kidney cells",
            "F": "I don't know"
        }
    },
    "14": {
        "question": "Which pathway is promoted by SeC@PA to induce macrophage polarization?",
        "options": {
            "A": "MAPK pathway",
            "B": "PI3K-Akt pathway",
            "C": "JAK-STAT6 pathway",
            "D": "NF-kB pathway",
            "E": "mTOR pathway",
            "F": "I don't know"
        }
    },
    "15": {
        "question": "According to Fig. 5, what is the effect of SeC@PA treatment on VEGF levels in RAW264.7 cells?",
        "options": {
            "A": "VEGF levels are unaffected",
            "B": "VEGF levels decrease",
            "C": "VEGF levels increase",
            "D": "VEGF is completely depleted",
            "E": "VEGF is only produced under hypoxic conditions",
            "F": "I don't know"
        }
    },
    "16": {
        "question": "What is the primary purpose of using the JAK-STAT6 pathway in the study?",
        "options": {
            "A": "To enhance antibacterial activity",
            "B": "To increase light absorption",
            "C": "To promote macrophage polarization towards M2",
            "D": "To reduce nanoparticle size",
            "E": "To boost collagen production",
            "F": "I don't know"
        }
    },
    "17": {
        "question": "What noticeable change occurs in HUVECs when treated with SeC@PA, according to the results?",
        "options": {
            "A": "Enhanced cell swelling",
            "B": "Increased migration and tube formation",
            "C": "Reduced mitotic activity",
            "D": "Increased adhesion to substrates",
            "E": "Minimal changes observed",
            "F": "I don't know"
        }
    },
    "18": {
        "question": "According to Fig. 6, what is the observed effect of SeC@PA MN on wound healing rate in diabetic chronic wounds?",
        "options": {
            "A": "No significant effect",
            "B": "Slows down healing compared to the control",
            "C": "Increases healing rate significantly",
            "D": "Similar healing rate as blank microneedle",
            "E": "Varies greatly between applications",
            "F": "I don't know"
        }
    },
    "19": {
        "question": "What is the key factor limiting the efficacy of PDT in diabetic wound treatment according to the study?",
        "options": {
            "A": "Light penetrability issues",
            "B": "Limited tissue compatibility",
            "C": "High glutathione levels in biofilms",
            "D": "High temperature of the treatment area",
            "E": "High sodium concentration in wound fluid",
            "F": "I don't know"
        }
    },
    "20": {
        "question": "According to Fig. 10, how does SeC@PA MN(+)'s polarization effect impact inflammatory cytokine levels?",
        "options": {
            "A": "Increase in pro-inflammatory cytokines",
            "B": "Decrease in anti-inflammatory cytokines",
            "C": "Increase in IL-4 and IL-10 levels",
            "D": "Decrease in cytokines across the board",
            "E": "No significant changes in cytokine levels",
            "F": "I don't know"
        }
    },
    "21": {
        "question": "What observed effect does SeC@PA MN have on CD31 expression, as demonstrated in Fig. 8?",
        "options": {
            "A": "Reduced CD31 expression",
            "B": "No effect on CD31 expression",
            "C": "Significant increase in CD31 expression",
            "D": "Irregular changes in CD31 expression",
            "E": "Complete loss of CD31 expression",
            "F": "I don't know"
        }
    },
    "22": {
        "question": "What is the impact of SeC@PA MN on oxidative stress in wound tissues?",
        "options": {
            "A": "Increase oxidative stress",
            "B": "Neutral effect on oxidative stress",
            "C": "Decrease oxidative stress by scavenging RS",
            "D": "Increase ROS levels indefinitely",
            "E": "No impact on oxidative stress",
            "F": "I don't know"
        }
    },
    "23": {
        "question": "What is the function of LA in the SeC@PA nanoparticles composition?",
        "options": {
            "A": "Preserve nanoparticle structure",
            "B": "Generate singlet oxygen",
            "C": "Produce nitric oxide",
            "D": "Enhance hydrophobicity",
            "E": "Reduce ROS formation",
            "F": "I don't know"
        }
    },
    "24": {
        "question": "What method was used to generate Se nanoparticles in the study?",
        "options": {
            "A": "Electrolysis",
            "B": "Centrifugal infusion",
            "C": "Laser ablation",
            "D": "Stirring reaction with vitamin C",
            "E": "Sol-gel processing",
            "F": "I don't know"
        }
    },
    "25": {
        "question": "What are the potential therapeutic applications of SeC@PA MN bandages suggested by the study?",
        "options": {
            "A": "Only infectious skin conditions",
            "B": "Long-term oxygen therapy",
            "C": "Various skin lesions including non-diabetic wounds",
            "D": "Treatment of bone fractures",
            "E": "Role in dental cavities management",
            "F": "I don't know"
        }
    },
    "26": {
        "question": "Why is the high glutathione concentration in biofilms problematic for ROS-driven therapies?",
        "options": {
            "A": "It inactivates ROS",
            "B": "It increases bacterial proliferation",
            "C": "It prevents oxygen delivery",
            "D": "It neutralizes antibiotics",
            "E": "It escalates thermal damage",
            "F": "I don't know"
        }
    },
    "27": {
        "question": "What primary advantage does the microneedle-based delivery provide in treating chronic wounds?",
        "options": {
            "A": "Allows for greater control over drug release timing",
            "B": "Enhances penetration of therapeutic agents",
            "C": "Reduces need for surgical application",
            "D": "Increases visibility of treatment area",
            "E": "Regulates patient's temperature",
            "F": "I don't know"
        }
    },
    "28": {
        "question": "How is the activity of GPX4 affected by the application of SeC@PA MN?",
        "options": {
            "A": "GPX4 activity is suppressed",
            "B": "There is no change in GPX4 activity",
            "C": "GPX4 activity increases significantly",
            "D": "GPX4 activity is inhibited temporarily",
            "E": "Only baseline levels of GPX4 are observed",
            "F": "I don't know"
        }
    },
    "29": {
        "question": "What phenomenon is observed when SeC@PA is delivered to environments with high GSH levels?",
        "options": {
            "A": "Formation of reactive oxygen species (ROS) is inhibited",
            "B": "SeC@PA is instantly deactivated",
            "C": "Enhanced production of reactive species for biofilm eradication",
            "D": "Conversion of SeC@PA to an inactive form",
            "E": "Complete absorption of SeC@PA by tissue",
            "F": "I don't know"
        }
    },
    "30": {
        "question": "What indicator was used to validate the anti-inflammatory effect of SeC@PA MN in the study?",
        "options": {
            "A": "Change in tissue color",
            "B": "Macrophage polarization towards M2",
            "C": "Reduction in wound temperature",
            "D": "Decrease in wound size",
            "E": "Increase in bacterial count",
            "F": "I don't know"
        }
    },
    "31": {
        "question": "Which cells did SeC@PA MNs significantly promote to secrete VEGF, enhancing wound healing?",
        "options": {
            "A": "Fibroblasts",
            "B": "Keratinocytes",
            "C": "RAW264.7 cells (macrophages)",
            "D": "Neutrophils",
            "E": "Erythrocytes",
            "F": "I don't know"
        }
    },
    "32": {
        "question": "According to the results, what unique 'storm' was initiated by SeC@PA through GSH exploitation?",
        "options": {
            "A": "Oxygen storm",
            "B": "Nitrogen storm",
            "C": "Reactive species (RS) storm",
            "D": "Thermal storm",
            "E": "Enzyme storm",
            "F": "I don't know"
        }
    },
    "33": {
        "question": "Which type of nanoparticle size distribution was observed for SeC@PA?",
        "options": {
            "A": "Polydisperse",
            "B": "Wide-range",
            "C": "Uniform",
            "D": "Non-specific",
            "E": "Inconsistent",
            "F": "I don't know"
        }
    },
    "34": {
        "question": "What key histological change was observed in wounds treated with SeC@PA?",
        "options": {
            "A": "Increased formation of fibrous tissue",
            "B": "Decreased presence of inflammatory cells",
            "C": "No significant histological change",
            "D": "Complete necrosis",
            "E": "Enhanced gland formation",
            "F": "I don't know"
        }
    },
    "35": {
        "question": "As indicated in the study, what was the outcome of SeC@PA treatment on macrophage surface markers?",
        "options": {
            "A": "Increased CCR7 expression",
            "B": "Reduction only in M1 markers",
            "C": "Increase in CD206 expression",
            "D": "No changes in any marker expression",
            "E": "Depletion of all marker expression",
            "F": "I don't know"
        }
    },
    "36": {
        "question": "What is the approximate diameter of Se particles used in the study?",
        "options": {
            "A": "5 nm",
            "B": "38 nm",
            "C": "100 nm",
            "D": "150 nm",
            "E": "200 nm",
            "F": "I don't know"
        }
    },
    "37": {
        "question": "What was used as the positive control treatment in the biofilm eradication experiment?",
        "options": {
            "A": "C@PA",
            "B": "Se@PA",
            "C": "SeC@PA(\u2212)",
            "D": "Blanks",
            "E": "Antibiotic solution",
            "F": "I don't know"
        }
    },
    "38": {
        "question": "What happens to the DCF fluorescence intensity when RS levels are elevated by SeC@PA?",
        "options": {
            "A": "It remains unchanged",
            "B": "It decreases",
            "C": "It dramatically increases",
            "D": "It reaches equilibrium",
            "E": "It begins to pulse",
            "F": "I don't know"
        }
    },
    "39": {
        "question": "Which specific imaging technique was used to assess the morphology of SeC@PA in the study?",
        "options": {
            "A": "X-ray tomography",
            "B": "Magnetic resonance imaging (MRI)",
            "C": "Transmission electron microscopy (TEM)",
            "D": "Fluorescence resonance energy transfer (FRET)",
            "E": "Atomic force microscopy (AFM)",
            "F": "I don't know"
        }
    },
    "40": {
        "question": "How is singlet oxygen utilized in the context of the SeC@PA treatment shown in the study?",
        "options": {
            "A": "It is used to stabilize enzymes",
            "B": "It facilitates nutrient absorption",
            "C": "It aids in ROS generation",
            "D": "It is used as a pH indicator",
            "E": "It does not play any role",
            "F": "I don't know"
        }
    },
    "41": {
        "question": "What is the main therapeutic strategy introduced in this article for treating diabetic wounds?",
        "options": {
            "A": "Chemotherapy",
            "B": "Radiation therapy",
            "C": "Self-enhancing photodynamic therapy with immunomodulation",
            "D": "Hyperbaric oxygen therapy",
            "E": "Acupuncture",
            "F": "I don't know"
        }
    },
    "42": {
        "question": "Which animal model was used to test the treatment efficacy of SeC@PA MN in vivo?",
        "options": {
            "A": "Rabbits",
            "B": "Guinea pigs",
            "C": "Mice",
            "D": "Zebrafish",
            "E": "Fruit flies",
            "F": "I don't know"
        }
    },
    "43": {
        "question": "What specific problem in wound healing is addressed by using microneedles in the study?",
        "options": {
            "A": "Reduction of body temperature",
            "B": "Alleviating systemic symptoms",
            "C": "Penetrating wound covering barriers",
            "D": "Raising pH levels around wound",
            "E": "Increasing electrolyte levels",
            "F": "I don't know"
        }
    },
    "44": {
        "question": "The results show that SeC@PA leads to the polarization of which macrophage phenotype?",
        "options": {
            "A": "M1 type",
            "B": "Invariant macrophage",
            "C": "M0 type",
            "D": "M2 type",
            "E": "Transitory type",
            "F": "I don't know"
        }
    },
    "45": {
        "question": "What effect did SeC@PA have on the GSH levels in biofilms compared to controls?",
        "options": {
            "A": "SeC@PA increased GSH",
            "B": "Comparable to controls",
            "C": "SeC@PA decreased GSH levels",
            "D": "Complete depletion of GSH levels by SeC@PA",
            "E": "Fluctuations in GSH levels",
            "F": "I don't know"
        }
    },
    "46": {
        "question": "Why is the balance of RS generation and scavenging crucial for wound healing in diabetic wounds?",
        "options": {
            "A": "To maintain protein structure",
            "B": "To achieve optimal vascularization",
            "C": "To prevent further oxidative stress and tissue damage",
            "D": "To increase epidermal thickness",
            "E": "To ensure electrical conductivity",
            "F": "I don't know"
        }
    },
    "47": {
        "question": "In terms of the experimental setup, what crucial factor is controlled during PDT irradiation in the study?",
        "options": {
            "A": "Sound frequency",
            "B": "Magnetic field intensity",
            "C": "Irradiation intensity and duration",
            "D": "Temperature gradations",
            "E": "Humidity levels",
            "F": "I don't know"
        }
    },
    "48": {
        "question": "What specific test measures NO production capabilities of SeC@PA?",
        "options": {
            "A": "Chromatography",
            "B": "Spectrophotometry for absorbance at 550 nm",
            "C": "Gel electrophoresis",
            "D": "Mass spectrometry",
            "E": "NMR spectroscopy",
            "F": "I don't know"
        }
    },
    "49": {
        "question": "According to the study, why is the dual regulatory effect on RS beneficial for chronic wound treatment?",
        "options": {
            "A": "Ensures complete elimination of RS",
            "B": "Optimizes nutrient supply",
            "C": "Balances between anti-biofilm activity and anti-inflammatory effect",
            "D": "Synchronizes electrical impulses",
            "E": "Mediates thermal conditions",
            "F": "I don't know"
        }
    },
    "50": {
        "question": "Which protein's activity is enhanced in HUVECs to promote antioxidation through SeC@PA?",
        "options": {
            "A": "Albumin",
            "B": "Hemoglobin",
            "C": "Glutathione peroxidase (GPX4)",
            "D": "Keratin",
            "E": "Collagen",
            "F": "I don't know"
        }
    }
}